Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Fingolimod market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Fingolimodmarket, defines the market attractiveness level of Fingolimod market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Fingolimod industry, describes the types of Fingolimod market, the applications of major players and the market size, and deeply analyzes the current situation of the global Fingolimod market and the development prospects and opportunities of Fingolimod industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Fingolimod market in Chapter 13.
By Player:
Novartis
AstraZeneca
By Type:
Oral
Injection
By End-User:
Medical Field
Science Research Field
Other Field
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Fingolimod Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Fingolimod Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Fingolimod Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Fingolimod Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Fingolimod Market Analysis and Outlook to 2022
-
7.1 Global Fingolimod Consumption (2017-2022)
-
7.2 United States Fingolimod Consumption (2017-2022)
-
7.3 Europe Fingolimod Consumption (2017-2022)
-
7.4 China Fingolimod Consumption (2017-2022)
-
7.5 Japan Fingolimod Consumption (2017-2022)
-
7.6 India Fingolimod Consumption (2017-2022)
-
7.7 South Korea Fingolimod Consumption (2017-2022)
8 Region and Country-wise Fingolimod Market Analysis and Outlook to 2028
-
8.1 Global Fingolimod Consumption Forecast (2022-2028)
-
8.2 United States Fingolimod Consumption Forecast (2022-2028)
-
8.3 Europe Fingolimod Consumption Forecast (2022-2028)
-
8.4 China Fingolimod Consumption Forecast (2022-2028)
-
8.5 Japan Fingolimod Consumption Forecast (2022-2028)
-
8.6 India Fingolimod Consumption Forecast (2022-2028)
-
8.7 South Korea Fingolimod Consumption Forecast (2022-2028)
9 Global Fingolimod Market Outlook by Types and Applications to 2022
-
9.1 Global Fingolimod Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Oral Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Injection Consumption and Growth Rate (2017-2022)
-
9.2 Global Fingolimod Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Medical Field Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Science Research Field Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Other Field Consumption and Growth Rate (2017-2022)
10 Global Fingolimod Market Outlook by Types and Applications to 2028
-
10.1 Global Fingolimod Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Oral Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Injection Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Fingolimod Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Medical Field Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Science Research Field Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Other Field Consumption Forecast and Growth Rate (2022-2028)
11 Global Fingolimod Import and Export Analysis (Top 5 Countries)
-
11.1 Global Fingolimod Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Fingolimod Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Fingolimod Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Fingolimod Market Competitive Analysis
-
14.1 Novartis
-
14.1.1 Novartis Company Details
-
14.1.2 Novartis Fingolimod Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Novartis Fingolimod Product and Service
-
14.2 AstraZeneca
-
14.2.1 AstraZeneca Company Details
-
14.2.2 AstraZeneca Fingolimod Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 AstraZeneca Fingolimod Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Fingolimod
-
Figure Fingolimod Picture
-
Table Global Fingolimod Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Fingolimod Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Fingolimod Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Fingolimod Consumption by Country (2017-2022)
-
Figure United States Fingolimod Consumption and Growth Rate (2017-2022)
-
Table Europe Fingolimod Consumption and Growth Rate (2017-2022)
-
Figure China Fingolimod Consumption and Growth Rate (2017-2022)
-
Figure Japan Fingolimod Consumption and Growth Rate (2017-2022)
-
Figure India Fingolimod Consumption and Growth Rate (2017-2022)
-
Figure South Korea Fingolimod Consumption and Growth Rate (2017-2022)
-
Figure Global Fingolimod Consumption Forecast by Country (2022-2028)
-
Figure United States Fingolimod Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Fingolimod Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Fingolimod Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Fingolimod Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Fingolimod Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Fingolimod Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oral Consumption and Growth Rate (2017-2022)
-
Figure Global Injection Consumption and Growth Rate (2017-2022)
-
Figure Global Medical Field Consumption and Growth Rate (2017-2022)
-
Figure Global Science Research Field Consumption and Growth Rate (2017-2022)
-
Figure Global Other Field Consumption and Growth Rate (2017-2022)
-
Figure Global Oral Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Injection Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Medical Field Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Science Research Field Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Field Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Fingolimod Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Fingolimod Export by Region (Top 5 Countries) (2017-2028)
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Fingolimod Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Fingolimod Product and Service
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Fingolimod Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Fingolimod Product and Service
-
